Abstracts

Citation

Internally Validated Genetic Associations Reveal a Strong Relationship for HLA-Cw8 with Plasma HIV RNA and CCR5¿32 with CD4+ Lymphocyte Count among HIV Infected Antiretroviral Naïve Children.

Citation

Ross E. McKinney, Jr., M.D., Maria Leticia Santos Cruz, M.D., Christine Powell, M.A., Michael Hughes, Ph.D., Michael Hughes, Ph.D., James M. Oleske, M.D., Harland S. Winter, M.D., Carol Elgie, B.S., Lynette Purdue, Pharm.D., D. Wolf, Shiara Melissa Ortiz-Pujols, B.A., Nancy R. Calles, B.S.N., Nancy R. Calles, B.S.N., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D. International Formula-Based Nutritional Intervention for Infants Born to HIV-Infected Women.

Citation

Simone Fiore, M.D., Marie Louise Newell, M.D., Claire Thorne, Ph.D. Interventions to reduce vertical transmission of HIV in Europe. Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Citation

W Koay, J Lindsey, P Uprety, A Weinberg, M Levin, M Bwakura-Dangarembizi, D Persaud. Intestinal damage and inflammation in perinatally HIV-1-infected African infants. Presented at: CROI 2018; 2018 Mar 06.

Citation

J Aizire, KM Brooks, M Mirochnick, P Flynn, M Cababasay, JJ Kiser, G Siberry, T Fenton, K Butler, MG Fowler, PROMISE study team. Intracellular concentrations of tenofovir diphosphate (TFV-DP) during pregnancy in the PROMISE study: Description and relationship with adverse pregnancy outcomes. Presented at: IAS 2018.

Citation

John H. Rodman, Pharm.D., Mona Rigaud, M.D., Brian Robbins, Ph.D., Arnold Fridland, Ph.D., Jane C. Lindsey, Sc.D., Patricia M. Flynn, M.D., M.S. Intracellular Phosphorylated Anabolities of Zidovudine (Z) and Lamivudine (L) on Once (QD) versus Twice (BID) Daily Regimens i Peripheral Blood Mononuclear Cells (PBMCs) in HIV-infected Adolescents and Young Adults.

Citation

Kristina M. Brooks, Jiajia Wang, Jeremiah D. Momper, David E. Shapiro, Rachael Jeffrey, Renee Browning, Gretchen Buckler, Kevin Knowles, Chelsea Krotje, Brookie M. Best, Mark Mirochnick. Intracellular tenofovir- diphosphate concentrations with tenofovir alafenamide during pregnancy and postpartum in people with HIV: Results from IMPAACT 2026. Presented at: International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs.

Citation

Benjamin Chi, M.D., Lisa M. Frenkel, M.D., Grace M. Aldrovandi, MD, Namwinga Chintu, MMED, R. Cantrell, Felistas Mbewe, R.N., G. M. Ellis, Elizabeth Stringer, M.D., K. Nakamura, Jeffrey S.A. Stringer, M.D. Intrapartum tenofovir and emtricitabine reduces development of low-level NNRTI resistance following ingestion of single-dose nevirapine (NVP) for perinatal HIV prevention. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Zabrina L. Brumme, Carrie Ziemniak, Hanwei Sudderuddin, Katherine Luzuriaga, Coleen Cunningham, Tom Greenough, Deborah Persaud. Investigating genetic diversity and CTL escape burden in the replication-competent HIV reservoir in young adult participants of a historic therapeutic HIV vaccine trial. Presented at: HIV Persistence Meeting.

Citation

Bryan S. Nelson, Camlin Tierney, Deborah Persaud, Jennifer Jao, Mark F. Cotton, Yvonne Bryson, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Dwight Yin, Ellen G. Chadwick, IMPAACT P1115 Team. IS ROUTINE PCP PROPHYLAXIS NEEDED IN VERY EARLY-TREATED INFANTS WITH HIV?. Presented at: CROI 2022; 2022 Feb 15.